Annapolis Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Annapolis Financial Services's PFE Position: Q3 2024 in Review
Annapolis Financial Services reduced its Pfizer (PFE) stake by 3.2% in Q3 2024, selling an estimated $729 and leaving 764 shares worth $22.1K. The position accounts for 0.01% of the portfolio, ranked #216.
Annapolis Financial Services first reported a position in PFE in Q4 2020 and has held it in 16 quarters since. The position peaked at $198K in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- Annapolis Financial Services held 764 shares of Pfizer worth $22.1K as of Q3 2024.
- Annapolis Financial Services sold 25 Pfizer shares in Q3 2024, an estimated $729.
- Pfizer made up 0.01% of Annapolis Financial Services's portfolio in Q3 2024, its #216 holding.
- Annapolis Financial Services first reported a position in Pfizer in Q4 2020 and has held it in 16 quarters since.
- Annapolis Financial Services's Pfizer position peaked at $198K in Q4 2021.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on Annapolis Financial Services's 13F filing for Q3 2024, filed 16 Oct 2024.